Founder of Vivalis SA, Franck Charles Marie Grimaud is a businessperson who has been at the head of 9 different companies and is Chief Executive Officer & Director at Atlantic Biotherapies and Director General & Chief Business Officer at Valneva SE, Co-Managing Director at VALNEVA Austria GmbH, Director & Managing Director at Vaccines Holdings Sweden AB, Director & Deputy Chief Executive Officer at Valneva USA, Inc., Director & President at Valneva Canada, Inc. and Director & Deputy Chief Executive Officer at Intercell USA, Inc. (which are all subsidiaries of Valneva SE). Mr. Grimaud is also Chief Business Officer at Intercell Austria AG and on the board of 5 other companies.

Mr. Grimaud previously held the position of President & Managing Director at Smol Therapeutics SAS, Chairman of Vivalis Toyama Japan KK and President & Chief Executive Officer for Vivalis SA.

He received an MBA from the University of Ottawa.